[--[65.84.65.76]--]
Indices, stocks & MCX commodities

Professional-Grade
Options Analytics

Trading tools

FII / DII flows

Market headlines

All stock news

Equity news

8
  • NATCOPHARM

    Natco pharma: gets tentative fda approval for olaparib tablets; alembic pharmaceuticals will distribute in the u.s.; expected sales of around $1.4 billion in the u.s. by march 2026.

  • HDBFS

    Hdb financial: upcoming board meeting set for july 23 to consider fund raising.

  • INDIACEM

    India cements: q1fy27 cement sales realisation per ton 3,847 vs 3,791 (qoq), 1.5% increase (qoq); 3,770 per ton (yoy)

  • INDIACEM

    India cements: aims to increase green power usage from 6% to 80% by fy29.

  • PNB

    Pnb: aims to surpass ₹4 trillion in corporate loans by fy27

  • PNB

    Pnb: expects to earn between rs 900 million and rs 1 billion from treasury income each quarter.

  • PNB

    Pnb: plans to open 250 new branches in fy27 targeting southern and western regions.

  • PNB

    Pnb: aims to raise $2.5 billion via fcnr(b) deposits by the end of september.

Result news

8
  • ROSSARI

    Rossari biotech: q1 ebitda 806m rupees vs 678m (yoy) || q1 ebitda margin 11.56% vs 12.5% (yoy)

  • ROSSARI

    Rossari biotech: q1 revenue 6.97b rupees vs 5.43b (yoy)

  • ROSSARI

    Rossari biotech: q1 cons net profit 351m rupees vs 336m (yoy)

  • SANGAMIND

    Sangam india: q1 ebitda 1.1b rupees vs 576m (yoy) || q1 ebitda margin 12.3% vs 7.3% (yoy)

  • SANGAMIND

    Sangam india: q1 revenue 8.6b rupees vs 7.9b (yoy)

  • SANGAMIND

    Sangam india: q1 cons net profit 410m rupees vs 21m (yoy)

  • JKCEMENT

    Jk cement: q1 ebitda 6.4b rupees vs 6.7b (yoy) || q1 ebitda margin 16.5% vs 21.10% (yoy)

  • JKCEMENT

    Jk cement: q1 revenue 38.66b rupees vs 31.9b (yoy)

Built for traders

Real-time Data

Live market data with sub-second refresh rates for time-sensitive decisions

Institutional Flow

Track FII/DII activity across cash and derivatives segments

Deep Analytics

Strike-level OI, Greeks, IV analysis with multi-expiry comparison

Historical Data

Access years of historical OI, price, and volume data for backtesting

Custom Dashboards

Build personalized views with drag-and-drop widgets

Mobile Ready

Full-featured responsive design for trading on the go

Simple pricing

Monthly Perfect for getting started
399 /month
  • Ad-free experience
  • Multi-interval analysis
  • Auto data refresh
  • MyView dashboard
View plans
Yearly Best value for long-term traders
4199 /year
Save ₹1,596 (27% off)
  • All features in Quarterly
  • Best value plan
  • Priority support 24/7
  • Save more annually
View plans

Ready to trade smarter?

Join thousands of traders using NiftyInvest to make data-driven decisions. Start your free trial today.

50K+ Active Traders
1M+ Daily Data Points
99.9% Uptime